Literature DB >> 27721036

CSF tau correlates with the degree of cortical involvement in E200K familial Creutzfeldt-Jakob disease.

Oren S Cohen1, Joab Chapman2, Amos D Korczyn3, Oliver L Siaw4, Naama Warman-Alaluf5, Zeev Nitsan6, Shmuel Appel6, Esther Kahana6, Hanna Rosenmann7, Chen Hoffmann8.   

Abstract

Cerebrospinal fluid (CSF) tau was found to correlate with disease severity and cognitive status in E200K familial Creutzfeldt-Jakob disease (fCJD) patients. The objective of the present study was to test whether tau levels in the CSF also correlate with the disease burden as reflected by the degree of cortical involvement in DWI MRI. Forty-four consecutive E200K fCJD patients (25 males, mean age 58.6±7.5, range 48-75 years) were recruited to the study and had a CSF tau examination as well as measurements of the extent of the cortical involvement in the DWI axial MRI. Correlation was tested using Pearson test. A significant correlation (r=0.617 p<0.0001) was found between CSF tau levels and the extent of cortical involvement. This correlation between tau levels and the disease burden reinforce the notion that tau can be used as a biomarker reflecting the extent of disease in patients with E200K fCJD.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Creutzfeldt-Jakob disease; Disease severity; E200K mutation; MRI; Tau protein

Mesh:

Substances:

Year:  2016        PMID: 27721036     DOI: 10.1016/j.neulet.2016.10.012

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

Review 1.  Possible Function of Molecular Chaperones in Diseases Caused by Propagating Amyloid Aggregates.

Authors:  Vladimir F Lazarev; Elena R Mikhaylova; Irina V Guzhova; Boris A Margulis
Journal:  Front Neurosci       Date:  2017-05-16       Impact factor: 4.677

Review 2.  Role of Biomarkers for the Diagnosis of Prion Diseases: A Narrative Review.

Authors:  Miren Altuna; Iñigo Ruiz; María Victoria Zelaya; Maite Mendioroz
Journal:  Medicina (Kaunas)       Date:  2022-03-25       Impact factor: 2.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.